Most Read Articles
Natalia Reoutova, 21 Nov 2019

Final analysis of the POEMS (Prevention of Early Menopause) study finds that breast cancer (BC) patients treated with the gonadotrophin-releasing hormone agonist (GnRHa) goserelin, in addition to chemotherapy, are more likely to avoid premature menopause and to become pregnant without negatively impacting disease-related outcomes.

Jairia Dela Cruz, 4 days ago
In breast cancer, especially hormone-negative tumours, an ultrasound-guided core biopsy (CNB) is useful for predicting pathologic complete response (pCR) to chemotherapy and may thus help to avoid surgery for some patients, a study has found.
Christina Lau, 08 Dec 2016

Icotinib improves progression-free survival (PFS) and objective response rate (ORR) vs whole-brain irradiation (WBI) plus chemotherapy in Chinese patients with non-small-cell lung cancer (NSCLC) and brain metastases, according to a phase III study presented recently at the 17th World Conference on Lung Cancer (WCLC).

Christina Lau, 14 Feb 2019
Progress in the treatment of rare cancers has been named Advance of the Year by the American Society of Clinical Oncology (ASCO).

Severe diabetic retinopathy poses increased cognitive impairment hazard

Jairia Dela Cruz
01 Nov 2019

Patients with moderate or worse diabetic retinopathy (DR) are at much higher odds of developing cognitive impairment, according to a Singapore study.

“Importantly, these findings were independent of key risk factors of cognitive impairment, such as duration of diabetes, HbA1c, education, refractive error, cardiovascular disease (CVD) and visual acuity,” the investigators said.

The study included 682 diabetic participants (mean age, 67.3 years; 44.4 percent female; 30.4 percent Chinese) from the Singapore Epidemiology of Eye Disease Study. DR was present in 199 participants (29.2 percent), among whom 142 (20.8 percent) had minimal/mild disease and 57 (8.4 percent) had moderate or worse disease.

Over the 6-year follow-up, 40 participants (5.9 percent) were found to have cognitive impairment based on Abbreviated Mental Test screening, corresponding to an incidence rate of 5.9 percent. This group of individuals was older, more likely to be female, of Indian ethnicity, had lower education and poorer presenting distance visual acuity (p-all<0.05). [Br J Ophthalmol 2019;103:1605-1609]

In multivariate analysis regression models, participants with any DR were more than twice as likely as those without the diabetic eye disease to have cognitive impairment (odds ratio [OR], 2.32, 95 percent CI, 1.07–5.03). The odds were threefold higher in participants with moderate or worse DR (OR, 3.41, 1.06–11.00).

“Although these results need to be interpreted with caution due to the small number of individuals with incident CI, the data suggest that the significant diabetes–cognitive impairment relationship observed in previous studies may have been driven by the presence of diabetic microvascular complications in these individuals,” according to the investigators, stressing that larger cohort studies are needed to verify the present data and establish underlying mechanisms.

Given that retinal and cerebral small vessels share similar embryological origin, size, structure and physiological characteristics, including the blood-brain and blood-retinal barrier, the investigators speculate that retinal abnormalities in DR may also signal abnormalities within the blood-brain barrier, leading to cognitive decline. [J Anat 2005;206:319-348]

“Our findings highlight the importance of systematic preventative strategies such as regular eye screening, to prevent and slow DR progression, notably advanced DR,” the investigators said.

Clinicians managing patients with DR should therefore consider incorporating cognitive impairment monitoring and treatment, which in turn can improve the quality of life in both patients and their caregivers, they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Natalia Reoutova, 21 Nov 2019

Final analysis of the POEMS (Prevention of Early Menopause) study finds that breast cancer (BC) patients treated with the gonadotrophin-releasing hormone agonist (GnRHa) goserelin, in addition to chemotherapy, are more likely to avoid premature menopause and to become pregnant without negatively impacting disease-related outcomes.

Jairia Dela Cruz, 4 days ago
In breast cancer, especially hormone-negative tumours, an ultrasound-guided core biopsy (CNB) is useful for predicting pathologic complete response (pCR) to chemotherapy and may thus help to avoid surgery for some patients, a study has found.
Christina Lau, 08 Dec 2016

Icotinib improves progression-free survival (PFS) and objective response rate (ORR) vs whole-brain irradiation (WBI) plus chemotherapy in Chinese patients with non-small-cell lung cancer (NSCLC) and brain metastases, according to a phase III study presented recently at the 17th World Conference on Lung Cancer (WCLC).

Christina Lau, 14 Feb 2019
Progress in the treatment of rare cancers has been named Advance of the Year by the American Society of Clinical Oncology (ASCO).